In one study, 12-week treatment with insulin glargine vs liraglutide (mean dose = 1.3 mg/day) showed similar glycemic control and decrease of hepatic fat burden, although a reduction in BMI was only observed in the liraglutide-treated patients (68)
This happened at much higher non-physiologically relevant concentrations than that stimulated by glucagon previously demonstrated by Samols group (Samols, Marri, Marks, 1966)
Cyclic Peptide Structure : Contributes to receptor-binding stability and defined signaling activity
Feel like YOU again Enjoy more confidence, joy, and energy as you feel lighter and your clothes fit better
Ggebakan O, Kohl A, Osterhoff MA, van Baak MA, Jebb SA, Papadaki A, et al